13.23
Overview
News
Price History
Option Chain
Why RDY Down?
Discussions
Forecast
Stock Split
Dividend History
Dr Reddys Laboratories Ltd Adr stock is traded at $13.23, with a volume of 999.29K.
It is up +0.53% in the last 24 hours and up +3.52% over the past month.
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
See More
Previous Close:
$13.16
Open:
$13.1
24h Volume:
999.29K
Relative Volume:
0.58
Market Cap:
$2.20B
Revenue:
$3.47B
Net Income/Loss:
$668.83M
P/E Ratio:
3.297
EPS:
4.0127
Net Cash Flow:
$253.46M
1W Performance:
-0.45%
1M Performance:
+3.52%
6M Performance:
-16.57%
1Y Performance:
-10.40%
Dr Reddys Laboratories Ltd Adr Stock (RDY) Company Profile
Compare RDY with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
RDY
Dr Reddys Laboratories Ltd Adr
|
13.23 | 2.20B | 3.47B | 668.83M | 253.46M | 4.0127 |
![]()
ZTS
Zoetis Inc
|
163.50 | 72.50B | 9.26B | 2.49B | 2.30B | 5.47 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.98 | 47.08B | 30.25B | 1.37B | 5.08B | 0.4257 |
![]()
HLN
Haleon Plc Adr
|
10.16 | 45.99B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.29 | 17.52B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
312.26 | 13.78B | 2.76B | 1.11B | 898.10M | 22.77 |
Dr Reddys Laboratories Ltd Adr Stock (RDY) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-19-24 | Downgrade | Nomura | Buy → Neutral |
Jan-11-24 | Downgrade | Jefferies | Buy → Underperform |
Aug-29-23 | Downgrade | HSBC Securities | Buy → Hold |
May-18-23 | Downgrade | Bernstein | Outperform → Mkt Perform |
Mar-17-23 | Upgrade | BofA Securities | Neutral → Buy |
Jan-30-23 | Initiated | JP Morgan | Underweight |
Nov-14-22 | Downgrade | Credit Suisse | Neutral → Underperform |
Jan-03-22 | Resumed | BofA Securities | Neutral |
Jul-27-21 | Downgrade | Credit Suisse | Outperform → Neutral |
Feb-02-21 | Upgrade | Barclays | Equal Weight → Overweight |
Sep-18-20 | Upgrade | BofA Securities | Neutral → Buy |
Sep-18-20 | Upgrade | Investec | Sell → Hold |
Jan-28-20 | Downgrade | CLSA | Buy → Outperform |
Jan-27-20 | Downgrade | CLSA | Buy → Outperform |
Jan-09-20 | Upgrade | Citigroup | Sell → Buy |
Nov-04-19 | Downgrade | BofA/Merrill | Buy → Neutral |
Sep-04-19 | Upgrade | Credit Suisse | Underperform → Outperform |
Jul-01-19 | Upgrade | Macquarie | Neutral → Outperform |
Jun-20-19 | Initiated | Deutsche Bank | Hold |
Jun-11-19 | Initiated | Barclays | Equal Weight |
May-20-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Feb-19-19 | Upgrade | CLSA | Outperform → Buy |
Jan-17-19 | Downgrade | Citigroup | Neutral → Sell |
Sep-21-17 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Aug-31-17 | Upgrade | CLSA | Underperform → Outperform |
Jul-28-17 | Downgrade | CLSA | Underperform → Sell |
Jul-27-16 | Downgrade | HSBC Securities | Hold → Reduce |
Jul-27-16 | Downgrade | Jefferies | Hold → Underperform |
Feb-10-16 | Upgrade | Credit Agricole | Underperform → Buy |
Nov-10-15 | Downgrade | Citigroup | Buy → Neutral |
View All
Dr Reddys Laboratories Ltd Adr Stock (RDY) Latest News
Asian Equities Traded in the US as American Depositary Receipts Trending Lower in Wednesday Trading - TradingView
American Healthcare REIT Inc (AHR) Stock: A Year of Decreases and Increases - The InvestChronicle
Asian Equities Traded in the US as ADRs Rise in Tuesday Trading - MSN
Asian Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading - TradingView
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Asian Equities Traded in the US as American Depositary Receipts Lower in Friday Trading - TradingView
Infosys, Wipro, TCS, other IT stocks fall up to 3% after Accenture Q2 results. Details here - Mint
Infosys, Wipro ADRs drop over 3% on NYSE after Accenture hikes full-year revenue guidance to 5-7% on AI boom - Mint
Asian Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading - TradingView
Asian Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading - TradingView
Asian Equities Traded in the US as American Depositary Receipts Track Sharply Lower in Tuesday Trading - TradingView
Asian Equities Traded in the US as American Depositary Receipts Open Week Sharply Higher - TradingView
Bioengineered Protein Drugs Market Size to Cross USD 672.7 Billion by 2034, Growing at a CAGR of 6.2% - GlobeNewswire Inc.
Asian Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading - TradingView
Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading - TradingView
Best upcoming stock splits and reverse splits 2024 - Investorsobserver
Asian Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading - TradingView
Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Up 1.5% for Week - TradingView
Is TG Therapeutics Inc (NASDAQ: TGTX) A Good Investment For New Investors Now? - Stocks Register
Senores Pharmaceuticals Shares: Rises 7%, acquires 14 ANDAs from Dr. Reddy’s - BusinessLine
Rhumbline Advisers Grows Position in Dr. Reddy's Laboratories Limited (NYSE:RDY) - MarketBeat
Dr. Reddy's Laboratories Ltd. Sponsored ADR to Host Earnings Call - ACCESS Newswire
Stocks to watch: Bharti Airtel, Wipro, Coforge, Dr Reddy’s, Vakrangee among shares to remain in focus today - Mint
Share Market Update – Dr Reddy Share Price Target 2025 - LDCCBank
Asian Equities Traded in the US as American Depositary Receipts Tumble in Monday Trading - TradingView
Alvotech heldur kynningarfund fyrir fjárfesta 27. mars 2025, eftir birtingu uppgjörs fyrir árið 2024 og fjórða ársfjórðung - GlobeNewswire Inc.
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading, Up 2.2% for Week - MSN
Its Stock Has Paid Off Big Time For Dr. Reddy’s Laboratories Ltd. ADR - SETE News
Marshall Wace, DE Shaw, Millennium Helped Drive China ADR Surges - Mint
Lester Murray Antman dba SimplyRich Increases Stock Position in Dr. Reddy's Laboratories Limited (NYSE:RDY) - MarketBeat
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading; End Week Up 2% - TradingView
Asian Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading - TradingView
Indian ADRs Alert! Why Infosys, Wipro, HDFC Bank, ICICI Bank, Dr Reddy's Lab Will Be In Focus On February 13? - Goodreturns
Taking on analysts’ expectations and winning: Dr. Reddy’s Laboratories Ltd. ADR (RDY) - SETE News
Dr. Reddy’s Laboratories Ltd. ADR [NYSE: RDY] Sees Decrease in Stock Value - Knox Daily
Nothing is Better Than Sociedad Quimica Y Minera de Chile S.A. ADR (SQM) stock at the moment - SETE News
Ecolab, Inc (ECL) expanding its growth trajectory ahead - SETE News
A look into Golar Lng (GLNG)’s deeper side - SETE News
Altria Group Inc [NYSE: MO] Sees Increase in Stock Value - Knox Daily
Moody’s Corp [MCO] Shares Jump Approximately 26.66% Over the Year - Knox Daily
Understanding the 1.67% Volatility Levels of Dr. Reddy’s Laboratories Ltd. ADR’s (RDY) Stock in the Past 30 Days - The News Heater
LLY Stock Quote Price and Forecast - CNN
Dr. Reddy’s Faces GST Penalty, Evaluates Appeal - TipRanks
Of 5 billionaires contesting today’s Delhi elections, 3 are from BJP: Know their net worths - Mint
Dr Reddy's Labs shares slide 6% post Q3 results. Should you buy, sell, or hold? - The Economic Times
Dr. Reddy’s Labs ADR earnings missed by $0.02, revenue fell short of estimates - Investing.com
Coupang Inc (NYSE: CPNG): A Blank Check? - Stocks Register
Dr. Reddy’s Q3 & 9MFY25 Financial Results - Business Wire
Dr Reddys Laboratories Ltd Adr Stock (RDY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):